Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

667.48
-7.8452-1.16%
Number of Gainers:59
Number of Losers:84
Number of Flat:10
PE:- -
High:674.97
Open:674.97
Low:658.46
Close:675.33
Volume:341.61M
Turnover:7.92B
Market Cap:461.48B
Float Cap:354.60B

Loading ...

Stevanato Group initiated with a Hold at Deutsche Bank

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Yesterday

Top Premarket Decliners

MT Newswires Live
·
Yesterday

These Two Hard-Hit Stocks are Poised for a Comeback, Says Fund Manager

Dow Jones
·
Yesterday

British Land Corrects Share Capital Figure, Confirms Voting Rights Total

TIPRANKS
·
Yesterday

Stevanato Group Spa : Deutsche Bank Initiates Coverage with Hold Rating and Target Price $22

THOMSON REUTERS
·
Yesterday

Ryan Specialty price target lowered to $40 from $43 at Mizuho

TIPRANKS
·
Yesterday

Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics

GlobeNewswire
·
Yesterday

Crypto-Linked Stocks Fall as Bitcoin Hits One-Week Low

Reuters
·
Yesterday

Coinbase, Robinhood Stocks Fall. the Crypto Rally is Facing a Perfect Storm.

Dow Jones
·
Yesterday

Coinbase Price Target Maintained with a $240.00/Share by BTIG

Dow Jones
·
Yesterday

Here's Why We're Watching RenovoRx's (NASDAQ:RNXT) Cash Burn Situation

Simply Wall St.
·
Yesterday

Turn Therapeutics Updates GX-03 Program and Pipeline Outlook

TIPRANKS
·
Yesterday

Robinhood Shares Dip 2% After the Trading Company Buys $25 Million in Bitcoin to Add to its Balance Sheet

TIPRANKS
·
Yesterday

Robinhood price target raised to $132 from $105 at Barclays

TIPRANKS
·
Yesterday

Coinbase price target raised to $149 from $95 at Barclays

TIPRANKS
·
Yesterday

Coinbase Falls 2.5%, Strategy Drops 3.3%, Robinhood Slips 2.2%

THOMSON REUTERS
·
Yesterday

Caribou Plunges as it Explores Sale, Scraps Cancer Programs

Reuters
·
Yesterday

Enliven Therapeutics Reaches Realignment With FDA on Final Design of Relcobatinib's Phase 3 Trial

MT Newswires Live
·
Yesterday

Ryan Specialty Group (RYAN) Gets a Buy from Barclays

TIPRANKS
·
Yesterday